Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

Post-Hospital Suicide Prevention Intervention for Patients With Schizophrenia-Spectrum Disorders

The current project is a pilot randomized controlled trial to test the Coping Long-term with Active Suicide Program for schizophrenia-spectrum disorders (CLASP-S) for patients following a psychiatric hospitalization. Participants will be assigned to enhanced treatment as usual (ETAU) alone vs CLASP-S plus ETAU. Participants complete assessments at baseline during their psychiatric hospitalization and at 3 months (mid-treatment) and 6 months (post-treatment) following discharge. The primary aim is to assess the feasibility and acceptability of CLASP-S. The secondary aim is to estimate the effects of CLASP-S on reducing suicidal thoughts and behaviors relative to ETAU.

Inclusion Criteria:

• suicidal thoughts or behaviors prior to hospital admission
• diagnosis of a schizophrenia-spectrum disorder
• receiving pharmacotherapy
• 18 years or older
• speaks/reads English

Exclusion Criteria:

• psychosis due to substance use or medical condition
• lack of phone access
• discharge to long-term facility